You just read:

New Sub-analysis Data Highlights the Benefit of LIXIANA®▼ (edoxaban) Over Warfarin in NVAF Patients According to More Comprehensive Stroke Risk Scoring

News provided by

Daiichi Sankyo Company, Limited

Aug 29, 2017, 08:00 ET